Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The history now shows a new revision entry (v3.5.2) and the previous revision (v3.5.0) has been removed from the version history.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:48.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the Record History and the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:44:27.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study record history now includes a new revision v3.4.3 and removes revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T10:15:33.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. The government funding notice banner previously shown on the page was removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:13:41.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new government funding notice was added and the recruitment status was updated to Active, not recruiting (revision v3.4.1, 2026-01-29). Earlier statuses such as insufficient accrual and Terminated were removed (revision v3.4.0, 2025-08-06).
    Difference
    2%
    Check dated 2026-02-04T00:23:21.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Show glossary option added and color-coded change legends introduced with explanatory text; revision notes moved to v3.4.0 (removing v3.3.4) and the No FEAR Act label capitalization updated.
    Difference
    1%
    Check dated 2026-01-27T23:52:55.000Z thumbnail image

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.